Literature DB >> 11461190

Homomeric and heteromeric interactions between wild-type and mutant phenylalanine hydroxylase subunits: evaluation of two-hybrid approaches for functional analysis of mutations causing hyperphenylalaninemia.

P J Waters1, C R Scriver, M A Parniak.   

Abstract

Phenylketonuria (PKU) is caused by mutations in the phenylalanine hydroxylase gene (PAH), while mutations in genes encoding the two enzymes (dihydropteridine reductase, DHPR, and pterin-4-alpha-carbinolamine dehydratase, PCD) required for recycling of its cofactor, tetrahydrobiopterin (BH(4)), cause other rarer disease forms of hyperphenylalaninemia. We have applied a yeast two-hybrid method, in which protein--protein interactions are measured by four reporter gene constructs, to the analysis of six PKU-associated PAH missense mutations (F39L, K42I, L48S, I65T, A104D, and R157N). By studying homomeric interactions between mutant PAH subunits, we show that this system is capable of detecting quite subtle aberrations in PAH oligomerization caused by missense mutations and that the observed results generally correlate with the severity of the mutation as determined by other expression systems. The mutant PAH subunits are also shown in this system to be able to interact with wild-type PAH subunits, pointing to an explanation for apparent dominant negative effects previously observed in obligate heterozygotes for PKU mutations. Based on our findings, the applications and limitations of two-hybrid approaches in understanding mechanisms by which PAH missense mutations exert their pathogenic effects are discussed. We have also used this technique to demonstrate homomeric interactions between wild-type DHPR subunits and between wild-type PCD subunits. These data provide a basis for functional studies on HPA-associated mutations affecting these enzymes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461190     DOI: 10.1006/mgme.2001.3198

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  3 in total

Review 1.  Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism.

Authors:  Ania C Muntau; Søren W Gersting
Journal:  J Inherit Metab Dis       Date:  2010-09-08       Impact factor: 4.982

2.  A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiency.

Authors:  Daelyn Y Richards; Shelley R Winn; Sandra Dudley; Lev Fedorov; Nicole Rimann; Beat Thöny; Cary O Harding
Journal:  Mol Genet Metab       Date:  2020-09-30       Impact factor: 4.797

3.  Analysis of the genotype-phenotype correlation in patients with phenylketonuria in mainland China.

Authors:  Nana Li; Chunhua He; Jing Li; Jing Tao; Zhen Liu; Chunyan Zhang; Yuan Yuan; Hui Jiang; Jun Zhu; Ying Deng; Yixiong Guo; Qintong Li; Ping Yu; Yanping Wang
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.